Promaxo

About Promaxo

Promaxo is a medical technology startup that specializes in providing innovative MRI solutions for prostate imaging and image-guided biopsies. The company aims to make MRI scans more accessible, convenient, and cost-effective for both patients and healthcare providers. Unlike traditional MRI systems, Promaxo's MRI does not require extensive facility upgrades, such as shielding or hazardous cryogens, making it a more practical option for regular medical offices.

The primary clients for Promaxo's technology are private medical practices, particularly those specializing in urology. By offering a compact and modular MRI system, Promaxo enables these practices to perform MRI scans on-site, eliminating the need to refer patients to external imaging centers or hospitals. This reduces the time patients and physicians spend waiting for scans and follow-up visits, thereby improving the overall quality of care and reducing patient anxiety.

Promaxo operates in the medical imaging market, which is seeing increased demand due to the rising utilization of MRI for various diagnostic purposes. The company's business model revolves around selling its MRI systems to medical practices. Promaxo generates revenue through the sale of these systems, which are designed to be cost-effective with low capital expenditure and operating costs. The company also benefits from existing CPT codes, which help clinics recover the capital cost of the MRI system in less than a year, depending on the type of practice.

Promaxo's technology leverages low magnetic fields to produce high-quality images quickly, without causing discomfort or harm to the patient. The company has a strong intellectual property portfolio with 60 issued and pending patents and has received multiple awards, including the prestigious TiE50 Award.

In summary, Promaxo is revolutionizing the medical imaging landscape by making MRI technology more accessible and affordable for private practices, ultimately enhancing patient care.